Device and method for delivering powdered medicament

The design of the dual-stage actuation mechanism solves the problems of inconsistency and blockage in the drug delivery system during endoscopic surgery, achieving precise drug delivery and effective system flushing, and ensuring the accuracy of drug delivery to the treatment site.

CN118903658APending Publication Date: 2024-11-08BOSTON SCIENTIFIC SCIMED INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410998528.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-12-03
Filing Date
2020-12-02
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies for drug delivery systems in endoscopic surgery suffer from problems such as inconsistent drug delivery rates and dosages, potential blockages, and inaccurate delivery of drugs to deep treatment sites.

Method used

A two-stage actuation mechanism is adopted, which switches between different actuator configurations to achieve independent control of the agent and fluid, including fluid flow without agent, fluid flow mixed with agent, and fluid flow without agent again, to prevent system blockage.

Benefits of technology

It achieves precise drug delivery, reduces system blockage, and ensures the accuracy and consistency of drug delivery to the treatment site.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903658A_ABST
    Figure CN118903658A_ABST
Patent Text Reader

Abstract

A device for delivering a medicament may include: a source of medicament; a mixing chamber for receiving a fluid and a medicament; an outlet in fluid communication with the mixing chamber to deliver fluid and medicament; and an actuator configured to: (1) deliver a first flow of a substantially medicament-free fluid through the outlet; (2) after delivering the first stream, delivering a second stream of fluid and medicament through an outlet; and (3) after delivering the second stream, delivering a third stream of substantially medicament-free fluid through the outlet.
Need to check novelty before this filing date? Find Prior Art

Description

(Division No. 202080081294.9) CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims priority to U.S. Provisional Patent Application No. 62 / 942,898, filed on December 3, 2019, the entire contents of which are incorporated herein by reference. Technical Field

[0002] Various aspects of the present disclosure generally relate to devices and methods for delivering medicaments. More specifically, various aspects of the present disclosure relate to devices for delivery of powdered medicaments, such as hemostatic agents. Background Art

[0003] In certain medical procedures, it may be necessary to stop or minimize bleeding inside the body. For example, endoscopic medical procedures may require hemostasis of bleeding tissue inside the gastrointestinal tract (e.g., in the esophagus, stomach, or intestines).

[0004] During endoscopic surgery, a user inserts the sheath of an endoscope into a patient's body cavity. During the procedure, the user controls the endoscope using the endoscope's handle. Tools are passed through the endoscope's working channel, for example, via ports in the handle, to deliver therapeutic agents to a surgical site located near the distal end of the endoscope. The surgical site is distal to the operator.

[0005] To achieve hemostasis at a remote site, a hemostatic agent may be delivered by inserting a device into a working channel of an endoscope. For example, delivery of an agent may be achieved by a mechanical system. However, such a system may require many steps or actuations to achieve delivery, may not achieve a desired rate of agent delivery or a desired dose of agent, may cause the agent to clog portions of the delivery device, may cause inconsistent dosing of the agent, or may cause the agent to reach a treatment site deep within the gastrointestinal tract. The present disclosure may address one or more of these problems or other problems in the art. Summary of the invention

[0006] Each aspect disclosed herein may include one or more features described in conjunction with any other disclosed aspect.

[0007] In one example, a device for delivering a medicament may include: a source of medicament; a mixing chamber for receiving a fluid and the medicament; an outlet in fluid communication with the mixing chamber for delivering the fluid and the medicament; and an actuator configured to (1): deliver a first flow of fluid substantially free of the medicament through the outlet; (2) delivering a second flow of fluid and the agent through the outlet after delivering the first flow; and (3) delivering a third flow of fluid substantially free of the agent through the outlet after delivering the second flow.

[0008] Any device disclosed herein may include any of the following features. The actuator may be transformed from a first configuration to a second configuration. In the first configuration, the source of the medicament is not in fluid communication with the mixing chamber. In the second configuration, the source of the medicament is not in fluid communication with the mixing chamber. The actuator includes a valve defining an opening. In the first configuration, the opening is not in fluid communication with the source of the medicament. In the second configuration, the opening is not in fluid communication with the source of the medicament. The valve includes a first portion and a second portion. A spring connects the first portion to the second portion. The valve is capable of transforming from the first configuration to the second configuration only when the flow of the fluid is flowing through the mixing chamber. The actuator includes a body pivoted via at least one of a piston or a line. The actuator may include a first rigid member and a second rigid member. The first rigid member is pivotally connected to the second rigid member. The second rigid member includes a trigger. The actuator includes a rotatable member having at least one blade extending from the rotatable member. The actuator may also include a gear. The actuator may include: a first actuator for controlling the flow of a medicament from a medicament source, and a second actuator for controlling the flow of a fluid. The first actuator and the second actuator are configured to be independently activated. The first actuator can be activated only when the second actuator is activated. The actuator includes a spring and a button valve. The actuator may include: a first portion; a second portion defining an opening; and a spring extending from the first portion to the second portion. In the first configuration and the third configuration, the opening is not in communication with the source fluid of the medicament. In the second configuration, the opening is not in communication with the source fluid of the medicament. The medicament may include powder. The actuator defines an opening. In the first configuration and the third configuration, the opening is not in communication with the source fluid of the medicament. In the second configuration, the opening is in communication with the source fluid of the medicament so that the powder can pass through the opening.

[0009] In another example, a device for delivering a medicament may include: a source of fluid; a source of powdered medicament; a mixing chamber for receiving the fluid and the powdered medicament; and an actuator configured to transition from a first configuration to a second configuration. In the first configuration, the source of medicament may not be in fluid communication with the mixing chamber, and a first flow of fluid substantially free of medicament is received in the mixing chamber. In the second configuration, the source of medicament may be in fluid communication with the mixing chamber, and a second flow of powdered medicament and fluid is received in the mixing chamber.

[0010] Any of the devices disclosed herein may have any of the following features. The actuator may be further configured to transition from the second configuration to the first configuration after transitioning from the first configuration to the second configuration.

[0011] In one example, a method of delivering a medicament may include: activating an actuator to cause: delivering a first flow of fluid, wherein the fluid is substantially free of the medicament; after delivering the first flow, delivering a second flow of fluid mixed with the medicament; and after delivering the second flow, delivering a third flow of fluid, wherein the fluid is substantially free of the medicament.

[0012] Any method or device disclosed herein may include any of the following features. The medicament may include a hemostatic agent. The fluid may be a pressurized fluid. During the delivery of the first and third streams, the opening of the actuator may not be in communication with the source fluid of the medicament. During the delivery of the second stream, the opening of the actuator may be in communication with the source fluid of the medicament.

[0013] It is understood that both the foregoing overview and the following detailed description are exemplary and explanatory only, and are not limitations on the invention as claimed. As used herein, the words "comprise", "comprising" or any other variant thereof are intended to cover non-exclusive inclusion, so that a process, method, article, or device comprising a sequence of elements not only includes these elements, but may also include other elements that are not explicitly listed or that are peculiar to such a process, method, article, or device. The word "exemplary" is used in an "exemplary" rather than an "ideal" sense. The word "distal" refers to a direction away from an operator, and the word "proximal" refers to a direction toward an operator. The word "approximately" or a word of the type (e.g., "substantially") includes a value of + / -10% of the stated value. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various aspects of the disclosure and together with the description, serve to explain the principles of the disclosure.

[0015] Figure 1A-Figure 1C Aspects of exemplary delivery devices are shown.

[0016] Figure 2A-Figure 7D A conveying device (comprising Figure 1A-Figure 1C Various exemplary actuation mechanisms of the conveying device). DETAILED DESCRIPTION

[0017] The dual-stage actuation mechanism can be used to deliver a medicament (e.g., a powdered medicament) from a delivery system to a medical surgical site. The actuation mechanism can be used to first deliver a fluid flow without the medicament to the site through the delivery system upon startup. Then, a mixed flow of fluid and medicament can be delivered. After the delivery of the desired amount of medicament, the fluid without the medicament can be delivered again. Before and after the delivery of the medicament, separate fluid delivery can facilitate flushing of the components of the delivery system and prevent blockage of the delivery system.

[0018] Figure 1A A delivery system 10 is shown, which may be a powder delivery system. The delivery system 10 may include a body 12. The body 12 may have a variety of features to be discussed in more detail herein. The features described herein may be used alone or in combination and are not mutually exclusive. Where possible, similar reference numerals and / or terms are used to represent similar structures.

[0019] Figure 1B A cross section of an exemplary body 12 is shown, which can be a component of the delivery system 10. The body 12 may include or may be configured to receive a housing 14 (or other source) storing a medicament 16. The housing 14 may be screwed onto the body 12 to provide the medicament 16 to the body 12, or a cap storing the medicament 16 may be screwed onto the housing 14 to provide the medicament 16 to the housing 14. The medicament 16 may be, for example, a powdered medicament (such as a hemostatic agent). Alternatively, the medicament 16 may be another type of medicament or medicament dosage form (e.g., a liquid or gel) and may have any desired function. The housing 14 may be removably attached to other components of the delivery system 10 (including components of the body 12). The body 12 may have a medicament inlet 18 that is fluidly connected to the housing 14 to receive the medicament 16 from the housing 14. The body 12 may include a fluid inlet 20 for receiving a fluid, such as a pressurized fluid, from a source 24 (e.g., a disposable tank, a tank, a supply line, etc.). The body 12 may include a Figure 1C 2. The nozzle 22 may include a nozzle chamber 25 that may be in fluid communication with the source 24. The nozzle chamber 25 may terminate in an opening 26. The diameter of the nozzle opening 26 may be between 0.015 and 0.030 inches (e.g., 0.020 inches). The opening 26 may be positioned generally along the longitudinal axis of the medicament inlet 18. The opening 26 may be located behind, slightly behind, slightly in front of, or directly in front of the medicament inlet 18.

[0020] The opening 26 can be in fluid communication with a mixing body 27 that defines a mixing chamber 28 for mixing the medicament 16 with the fluid from the source 24. The nozzle 22 can be connected to the mixing body 27 of the body 12 using any suitable fastening method (e.g., nuts, bolts, formed of continuous material with the mixing body 27, etc.). An O-ring 29a can be located in an annular seat 29b of the nozzle 22 to provide a seal between the nozzle 22 and the mixing body 27. The connection of the mixing body 27 to the housing 14 can use any suitable fastening method (such as screwing onto the mixing body 27, as shown), and can also include seals 31, 32 to provide a seal between the housing 14 and the mixing body 27 or other parts of the body 12.

[0021] The mixture of the medicament 16 and the fluid can be delivered from the outlet 34 of the body 12. The outlet 34 can be connected to a conduit 36 ​​(see Figure 1A) or other components are fluidly connected to deliver the mixture of the medicament 16 and the fluid to the desired position inside the patient's body cavity. The mixing chamber 28 can be in fluid communication with the outlet 34 and the mixing chamber 28, and the mixing chamber 28 and / or the outlet 34 can be configured to allow fluid connection with the catheter 36. The diameter / width of the outlet 34 can be the same or substantially the same as the diameter / width of the catheter 36 or the inner cavity of the catheter 36. The lack of an edge formed between the mixing body 27 (including the mixing chamber 28 and the outlet 34) can reduce the blockage of the medicament entering the catheter 36. The catheter can have an inner diameter of, for example, 0.080 inches, 0.050 inches, or 0.030 inches, and the size of the mixing chamber 28, the outlet 34, and / or the mixing body 27 can be designed for compatibility with the catheter size.

[0022] The delivery system 10 may include an actuation mechanism 30 for controlling the release of the medicament 16 and / or fluid via the outlet 34. For example, the actuation mechanism 30 may include a trigger, a button, a slider, a knob, a lever, or other suitable mechanism. The actuation mechanism may cause the medicament 14 and / or fluid to enter the mixing chamber 28, where the medicament 14 and the fluid may mix. As described below, the delivery system 10 may include more than one actuation mechanism 30. For example, multiple actuation mechanisms 30 may be used to individually control the flow of fluid through the fluid inlet 20 and the flow of medicament from the housing 14 through the medicament inlet 18.

[0023] Figure 2A-2C A cross-sectional view of an exemplary body is shown, which can be a component of the delivery system 10. The body 112 may include a medicament inlet 118, which can be in fluid communication with the housing 14 storing the medicament 16. The medicament inlet 118 can have an appropriate size to allow the passage of the medicament 16 therethrough. The medicament inlet 118 can have substantially the same size as the opening 152 described below. The medicament inlet 118 can be an opening formed in the body 112. The medicament inlet 118 can be a part of the housing 14, specifically wherein the housing 14 is not separable from the body 112. Alternatively, the housing 14 can include an opening formed therein, which can be in fluid communication with the medicament inlet 118. The body 112 can also include a fluid inlet 120, which is for receiving a fluid from a source 24 (see Figure 1C ). Figure 2B The arrow in FIG. 1 shows the direction of fluid flow into the inlet 120. The body 112 may also include a valve 138 for controlling the flow of fluid through the fluid inlet 120 and the flow of the medicament 16 through the medicament inlet 118. The valve 138 may be operably connected to the actuation mechanism 30 (see FIG. 1 ). Figure 1A ).

[0024] The valve 138 may include a first portion 140. The first portion 140 may have a first seal 142 and a second seal 144 received thereon. The first seal 142 and / or the second seal 144 may be, for example, an O-ring seal. The first portion 140 may also include a neck 148 between the first seal 142 and the second seal 144. The neck 148 may have a smaller cross-sectional diameter than other portions of the first portion 140 (e.g., those portions receiving the first seal 144 and the second seal 146).

[0025] The valve 138 may also include a second portion 150. The second portion 150 may define an opening 152. The opening 152 may extend through the entire thickness of the second portion 150 (but not through the entire width of the second portion 150) in a direction parallel to the longitudinal axis of the medicament inlet 118. The second portion 150 may have a third seal 154, a fourth seal 156, and a fifth seal 158 received thereon. The third seal 154 may be on a first side of the opening 152 closer to the first portion 140. The fourth seal 156 may be on a second opposite side of the opening 152. The fifth seal 158 may also be on a second side of the opening 152. The first portion 140 may be closer to the fourth seal 156 than the fifth seal 158.

[0026] The first spring 162 may extend between the first portion 140 and the second portion 150 and connect the first portion 140 to the second portion 150. The first spring 162 may be fixedly connected to an end 164 of the first portion 140 and to an end 166 of the second portion 150. The first portion 140 may taper to a first end 164, which may have a smaller cross-sectional diameter than other portions of the first portion 140. The second portion 150 may taper to a first end 166, which may have a smaller cross-sectional diameter than other portions of the second portion 150. The first end 166 may be the end of the second portion 150 closest to the third seal 154. The second spring 168 may extend from a second end 170 of the second portion 150. The second end 170 may be the end of the second portion 150 closest to the fifth seal 158. The first spring 162 may have a smaller spring constant than the second spring 168 (i.e., the first spring 162 may be a weaker spring than the second spring 168). Equal forces acting on the first spring 162 and the second spring 168 may cause the first spring 162 to be compressed more than the second spring 168 .

[0027] The valve 138 can be received in a cavity 200 of the body 112. The cavity 200 can be defined by a surface 202. The first cavity 200 can have a first opening 204, which is at one end of the cavity 200. The cavity 200 can have a second opening 206, which is in fluid communication with the fluid inlet 120 and the source 24. The third opening 208 of the cavity 200 can be in fluid communication with the fluid nozzle chamber 210. The fourth opening 212 of the cavity 200 can be in fluid communication with a mixing chamber 214, which can have any of the features of the mixing chamber 30. The fourth opening 212 can be aligned or substantially aligned with the medicament inlet 118 so as to be in selective fluid communication with the medicament inlet 118. The second spring 168 can contact the surface 202 at an end 205 of the cavity 200 opposite the end of the cavity 200 having the first opening 204.

[0028] The seals 142, 144, 154, 156, 158 may have dimensions and measurements on the durometer such that they form a seal with the surface 202 of the cavity 200. The seals 142, 144, 154, 156, 158 may also allow for sliding displacement of the valve 138 within the cavity 200.

[0029] Figure 2A The body 112 is shown in a first configuration, wherein the medicament 16 is not allowed to flow into the cavity 200 via the medicament inlet 118, and the fluid is not allowed to flow into the cavity 200 via the fluid inlet 120. The fourth seal 156 and the fifth seal 158 can be located on either side of the medicament inlet 118 so that the medicament 16 does not pass between the seals 156, 158 and the surface 202, thereby preventing the flow of the medicament 16. The first seal 142 and the second seal 144 can be located on either side of the fluid inlet 120. The seals 142, 144 can prevent the movement of fluid from the fluid inlet 120 between the seals 142, 144 and the surface 202. In the first configuration, the springs 162, 168 can be in a relaxed, uncompressed state.

[0030] Figure 2BThe body 112 is shown in a second configuration, wherein fluid is allowed to flow into the cavity 200 via the fluid inlet 120. In operation, when the actuation mechanism 30 is activated, the first portion 140 of the valve 138 may translate inside the cavity 200 in a first direction toward the end 205 of the cavity 200. The actuation mechanism 30 may be a separate component, or a surface of the valve 138 may function as the actuation mechanism and may receive force from the user's hand. The first portion 140 may initially apply a force acting on the spring 162, thereby causing the first spring 162 to compress. Because the first spring 162 is weaker than the second spring 168, and / or because the second portion 150 may not move until the first spring 162 is compressed by a selected amount, the second portion 150 may not immediately move along with the first portion 140.

[0031] like Figure 2B , in the second configuration, the entire second seal 144 is not in contact with the surface 202. For example, the second seal 144 can be aligned with a portion of the third opening 208. Thus, fluid from the fluid inlet 120 can pass between the first portion 140 and the surface 202 (e.g., along the neck 148). The fluid can then enter the fluid nozzle chamber 210 through the third opening 208. The fluid can then enter the mixing chamber 214 through the fluid nozzle opening 220. The fluid can then exit through the outlet 134.

[0032] exist Figure 2B In the second configuration, the second portion 150 may still remain in the same position or substantially the same position as in the first configuration ( Figure 2A ). Therefore, for the reasons described above, the medicament 16 will not be allowed to flow into the cavity 200 via the medicament inlet 118. As a result, only fluid from the source 24 can exit the outlet 134.

[0033] As the actuation mechanism 30 continues to be actuated, after the first spring 162 has been sufficiently compressed, when the force is sufficient to compress the second spring 168, the second portion 150 may begin to move in the first direction (to the left in the figure). Figure 2B ) to Figure 2C In the third configuration, the third seal 154 and the fourth seal 156 may be located on opposite sides of the medicament inlet 118, and the opening 152 of the second portion 150 may be aligned with the medicament inlet 118 so as to be in fluid communication with the medicament inlet 118. Thus, the medicament 16 may be allowed to enter the opening 152 via the medicament inlet 118. The medicament cannot pass between the third and fourth seals 154, 156 and the surface 202, thereby keeping the medicament 16 in a desired position so that it will pass through the opening 152.

[0034] At the same time, the first portion 140 may remain in the second configuration ( Figure 2B ) in the same position or substantially the same position. Thus, the fluid from source 24 can continue to flow, as described above with respect to Figure 2B The second spring 168 and / or the actuation mechanism 30 may be configured so that after the second spring 168 is compressed by a specified amount, neither the first portion 140 nor the second portion 150 may move further in the first direction to maintain Figure 2C In the third configuration, the second spring 168 may be fully compressed or may be only partially compressed.

[0035] After the medicament 16 passes through the opening 152, the medicament 16 may enter the mixing chamber 214 through the fourth opening 212. Here, the medicament 16 may mix with the fluid from the source 24. The mixture of the medicament 16 and the fluid from the fluid source 24 may then pass through the outlet 134 to be delivered to a desired location.

[0036] After the actuation mechanism 30 is no longer actuated, the restoring force of the second spring 168 can restore the valve 138 to the second configuration, in which fluid from the source 24 is delivered, but the medicament 16 is not delivered. Then, the restoring force of the first spring 162 can restore the valve 138 to the first configuration, in which neither the fluid from the source 24 nor the medicament 16 is delivered.

[0037] It should be understood that although the above description describes the second configuration ( Figure 2B ), but both the first spring 162 and the second spring 164 can be compressed in the second configuration so that the seals 142, 144, 154, 156, 158 are aligned in the manner described above to allow delivery of fluid only from the source 24. In addition, in the second configuration ( Figure 2B ) to the third configuration ( Figure 2C ), the first spring 162 will experience further compression (the first spring 162 will not be fully compressed in the second configuration).

[0038] In addition, it should be understood that there are many configurations of the valve 138 between the first configuration and the second configuration and between the second configuration and the third configuration. For example, there may be a configuration in which a portion of the medicament inlet 118 is covered and a portion of the medicament inlet 118 is aligned with the opening 152 so that the opening 152 is in fluid communication with the medicament inlet 118. In this configuration, it may be allowed to be more fluidic than in the third configuration ( Figure 2B ) A relatively small amount of the medicament 16 passes through the opening 152. With the valve 138 in the second configuration ( Figure 2B ) to the third configuration ( Figure 3B) transition, a larger portion of the drug inlet 118 will be aligned with the opening 152, thereby allowing an increasing amount of drug 16 to enter the opening 152.

[0039] Body 112 can facilitate delivery of fluid from source 24 free of or substantially free of medicament 16 through outlet 134 prior to delivery of medicament 16 and after delivery of medicament 16. Such delivery of fluid from source 24 free of or substantially free of medicament 16 can flush system 10, thereby reducing or eliminating clogging.

[0040] Figure 3A and Figure 3B An exemplary metering mechanism 250 is shown that may be used as part of the delivery system 10 . Figure 3A and Figure 3B Both show views of the housing 14 removed from the body 12 and looking toward the medication inlet 18 (i.e., the housing 14 will be removed from the body 12). Figure 3A and Figure 3B appears at the top of the page).

[0041] As in Figure 3A and Figure 3B As shown in , the metering mechanism 250 may include a door 252 that is pivotable about a fixed pivot point A, and the door 252 may be a knife-edge door having a very thin thickness in a direction parallel to the longitudinal axis of the medicament inlet 18. Figure 3A and Figure 3B As shown in , the door 252 can have a shape including any combination of straight edges and rounded edges. For example, the door 252 can have three straight edges and one rounded edge. The pivot point A can be located between a straight edge and a rounded edge.

[0042] The metering mechanism 250 may also include a piston 254. The piston 254 may be partially disposed inside a chamber 256, and the rod 258 of the piston 254 may extend through an opening 260 in the wall of the chamber 256. A spring 262 may also be disposed inside the chamber 256. The rod 258 of the piston 254 may extend along a central axis of the spring 258.

[0043] Chamber 256 may be fluidly connected to a source of fluid (e.g., source 24). When fluid 24 enters chamber 256, chamber 256 may be pressurized, and the fluid may exert a force on head 264 of piston (plunger) 254 in a first direction toward opening 260. The force from the fluid may cause piston 254 to move in the first direction. A seal (not shown) may be disposed between chamber 256 and one or both of rod 258 and head 264 so that the fluid cannot leave chamber 256. As piston 254 moves in the first direction (movement toward Figure 3A262, thereby generating a restoring force in a second direction opposite to the first direction. Movement of the piston 254 in the first direction may be stopped when any of the following occurs: (1) the head 264 presses against the surface of the chamber 256; (2) the restoring force of the spring 262 is equal to the force of the fluid acting on the piston 254; and / or (c) the spring 262 is fully compressed.

[0044] exist Figure 3A In the first configuration of the metering mechanism 250 shown in FIG. 2 , the spring 262 may be in a relaxed state (eg, when no fluid is being supplied to the chamber 256 ). The door 252 may be in a first position. Figure 3B A second configuration of the metering mechanism 250 is shown, wherein the spring 262 is compressed and the piston 254 has moved in the first direction (due to fluid supplied to the chamber 256). The door 252 may be in a second position.

[0045] When a user activates the actuation mechanism 30, fluid (e.g., from the source 24) may flow into the chamber 256. The piston 254 and the door 252 may be configured such that when fluid is provided to the chamber 256, as the piston 254 moves in the first direction, the piston 254 applies a force on the door 252 in the first direction. The force of the piston 254 may cause the door 252 to rotate about the pivot point A. As the door 252 rotates, it may expose the opening 266, which may be in fluid communication with a chamber (not shown) of the body 12. At first, after the piston 254 begins to move in the first direction, only a portion of the opening 266 may be exposed due to the rotation of the door 252. As the piston 254 continues to move in the first direction, the door 252 may continue to rotate, and more of the opening 266 may be exposed. When the piston 254 is fully exposed ( Figure 3B ), the entire opening 266 can be exposed. In the first position ( Figure 3A ), the door 252 covers the opening 266 so that the opening 266 is not connected to the housing 14 and no medicine 16 can enter the opening 266.

[0046] When the actuation mechanism 30 is no longer activated (activated), pressure can be released from the chamber 256 (via, for example, a release valve, which is not shown). Due to the restoring force of the spring 262, the spring 262 can push the head 264 of the piston 254 away from the opening 260 in the second direction. Therefore, the piston 254 no longer exerts a force on the door 252. The restoring force of the spring 262 can cause the piston 254 to return to the first configuration ( Figure 3A The door 252 may also be biased to return to the first configuration ( Figure 3A ). For example, the door 252 may be spring biased, such as at pivot point A.

[0047] In use, when the actuation mechanism 30 is activated, such activation causes fluid to flow through the fluid inlet 20 and out of the outlet 34. At the same time, as described above, the actuation mechanism 30 may begin to expose the opening 266. Due to the delay in pressurizing the chamber 256, or the delay in exposing the opening 266 when the chamber 256 is pressurized, a portion of the opening 266 is not immediately exposed. Additionally or alternatively, the size of the exposed portion of the opening 266 may be initially designed so that the medicament 16 does not flow through the opening 260, or only a small amount of the medicament flows through the opening 260. Therefore, initially after the actuation mechanism is activated, only the fluid from the source 24 without any medicament 16 may initially flow out of the outlet 34.

[0048] Similarly, when the actuating mechanism 30 starts or ends moving from the second configuration ( Figure 3B ) to the first configuration ( Figure 3A ), fluid may continue to be delivered via outlet 34. For example, actuation mechanism 30 may be configured such that chamber 256 is pressurized before fluid stops passing through fluid inlet 20. Opening 266 may be partially or completely covered by door 252 while fluid continues to pass through fluid inlet 20.

[0049] Metering mechanism 250 may facilitate delivery of fluid from source 24 free of or substantially free of medicament 16 through outlet 34 prior to delivery of medicament 16 and after delivery of medicament 16. This delivery of fluid from source 24 free of or substantially free of medicament 16 may flush system 10, thereby reducing or eliminating blockages.

[0050] Figure 4A-4B 1 shows a cross-sectional view of an exemplary body 312 for use with the delivery system 10. The body 312 may include a medicament inlet 318, which may be in fluid communication with the housing 14 storing the medicament 16. The body 312 may also include a fluid inlet 320 for receiving a fluid from the source 24 (see Figure 1B The body 312 may also include a metering mechanism 330 for controlling the flow of the fluid through the fluid inlet 320 and the flow of the medicament 16 through the medicament inlet 318. The metering mechanism 330 may have any of the features of the metering mechanism 250.

[0051] The metering mechanism 330 may include a door 332, which may have any of the characteristics of the door 252. The door 332 may be configured to rotate about a hinge B. The door 332 may also be operably connected to a wire 333. For example, a portion of the door 332 on the opposite side of the door 332 relative to the hinge B may be operably (movably) connected to the wire 333. The first end 336 of the wire 333 may be attached to a ridge 338 that extends from an edge of the door 332 in a direction parallel to the longitudinal axis of the medication inlet 318.

[0052] The second end 340 of the wire 333 may be operably connected to a valve 350. The valve 350 may be operably connected to the actuation mechanism 30 or may include a surface that functions as the actuation mechanism 30 by receiving contact from a user's finger. The valve 350 may be received within a fluid channel 352, which may be fluidly connected to the fluid inlet 320 and the fluid nozzle chamber 322. The longitudinal axis of the valve 350 may be approximately perpendicular to the longitudinal axis of the fluid channel 352. The valve 350 may also be received within a valve channel 354, which may have a longitudinal axis approximately parallel to the longitudinal axis of the valve 350. The valve 350 may include first, second and third seals 356, 358, 360, which may be, for example, O-ring seals. The seals 356, 358, 360 may prevent air from entering the valve channel 354 from the fluid channel 352. The valve 350 may be sized and constructed of a material such that in Figure 4A In the configuration of , valve 350 blocks fluid passage 352 so that fluid from fluid inlet 320 can enter fluid nozzle chamber 322 without passing through valve 350. For example, valve passage 354 can have a larger cross-sectional area than the cross-sectional area of ​​fluid passage 352, and valve 350 can occupy all or substantially all of valve 354.

[0053] The door 332 can be biased so that when no force is applied from the wire 333 to the door 332 and the door 332 is in a relaxed configuration, the door 332 is generally perpendicular or transverse to the central longitudinal axis of the medicament inlet 318 so that the medicament 16 does not pass through the door 332 and through the fluid inlet 320. For example, the door 332 can be spring biased at the pivot point B. Figure 4A A first configuration of the body 312 is shown, wherein the door 332 is in a relaxed configuration, effectively closing the medicament inlet 318 such that the medicament inlet 318 is not in communication with the mixing chamber 372 .

[0054] The valve 350 is movable in a first direction and a second direction that are perpendicular to the longitudinal axis of the fluid passage 352 and parallel to the longitudinal axis of the valve passage 354. As the valve 350 moves in the first direction, the narrowing portions 351 of the valve 350 may move so that they are disposed inside the fluid passage 352, and fluid may move through the valve 350. The narrowing portions 351 may have a cross-sectional area that is smaller than the fluid passage 352 so that the fluid may pass through the valve 350. Thus, the movement of the valve 350 in the first direction may initiate the flow of fluid from the fluid inlet 320 into the fluid nozzle chamber 322.

[0055] Movement of valve 350 in the first direction can compress spring 362. When spring 362 is in the intermediate relaxed configuration, door 332 can also be in its relaxed configuration (a configuration in which door 332 is biased) so that medicament 16 does not flow through door 332 into medicament inlet 318.

[0056] As the valve 350 moves in the first direction, the valve 350 can move the second end 340 of the wire 333 in the first direction (to Figure 4A-4B 333). As a result, the first end 336 of the wire 333 can move in a first direction. Alternatively, the first end 336 of the wire 333 can move in another direction such that the force from the first end 336 of the wire 333 causes the door 332 to pivot about the hinge B. The wire 333 can pass over the pulley 364 to accommodate space for other components of the body 312 and / or the conveying system 10.

[0057] When the first end 336 of the wire 333 moves in the first direction, the first end 336 can exert a force on the ridge 338 in the first direction, which can cause the door 332 to pivot such that the angle between the door 332 and the fluid inlet 320 increases (becomes closer to 180 degrees) as the door 332 pivots. As the door 332 pivots, the medicament 16 can begin to flow through the medicament inlet 318 and the door 332. The valve 350 and / or the door 332 can stop moving when one or more of the following occurs: the door 332 contacts a surface defining the medicament inlet 318 or other structure of the body 312, the spring 362 reaches maximum compression against a surface of the valve passage 354, or a surface of the valve 350 reaches a stop (not shown). Figure 4B The body 312 is shown in a second configuration in which the door 332 is fully open.

[0058] When the actuation mechanism 30 is initially activated, the door 332 may be gradually pulled away from the medicament inlet 318, but before any medicament 16 or a perceptible amount of medicament 16 can enter the mixing chamber 372, the fluid may flow through the fluid nozzle chamber 322, enter the mixing chamber 372, and then flow out of the outlet 334. The opening of the door 332 may occur after the valve 350 allows the fluid to flow out of the fluid inlet 320. With further actuation of the actuation mechanism 30, once the door 332 is opened to a sufficient amount, the medicament 16 may enter the mixing chamber 372 to mix with the fluid and be delivered from the outlet 334. After the actuation mechanism 30 is deactivated, the door 332 may begin to return to its unbiased position. The closing of the medicament inlet 318 allows the fluid to flow out of the outlet 334 without any or perceptible amount of medicament 16 entering the mixing chamber 372. The flow of fluid without medicament 16 or an appreciable amount of medicament 16 before and after the flow of fluid mixed with medicament 16 may alleviate clogging of portions of system 10 .

[0059] Alternatively, other portions of body 312 may facilitate the flow of fluid without medicament 16 before and after the flow of fluid mixed with medicament 16. For example, properties of spring 362 and / or relaxation of wire 333 may delay the opening of door 332, and / or actuation mechanism 30 may be configured to allow valve 350 to be opened before movement of valve 350 in the first direction begins and after delivery of medicament 16 ( Figure 3A ) after returning to its non-biased configuration. Body 312 can facilitate delivery of fluid from source 24 free of or substantially free of agent 16 through outlet 334 before and after delivery of agent 16. Such delivery of fluid from source 24 free of or substantially free of agent 16 can flush system 10, thereby reducing or eliminating blockages.

[0060] Figure 5A-Figure 5B A cross-sectional view of an exemplary body 412 is shown, which can be part of the delivery system 10. The body 412 can include a metering mechanism 430. The metering mechanism 430 can include a slider 432 (a first rigid member) that can be made of any suitable material (e.g., plastic, metal, composite material, polymer, etc.). The slider 432 can be made of a rigid or substantially rigid material. The slider 432 can include an opening 436 formed therein. The slider 432 can be configured to translate or slide relative to the remainder of the body 412 in a first direction and a second direction. The longitudinal axis of the slider 432 can be transverse to (e.g., perpendicular to) the longitudinal axis of the medicament inlet 418, and the movement of the slider 432 can be an axial movement along the longitudinal axis of the slider 432.

[0061] Slider 432 may be pivotally coupled to arm 438 (second rigid member) via, for example, hinge 437. Slider 432 may be received within a channel (not shown) or constrained so that slider 432 can only translate in first and second directions (i.e., axial movement). Hinge 437 may similarly translate within the channel. Arm 438 may rotate about axis C, which extends into and out of the channel. Figure 5A and Figure 5B The page shown in . Figure 5C 438. The arm 438 may include a trigger 440 at one end of the arm 438. The trigger 440 may be contacted by a user to rotate the arm 438 about the axis C and thereby translate the slide 432. The arm 438 may have a generally rectangular shape, such as Figure 5C . An opening 439 in the arm 438 can receive a component of the body 412 (eg, the fluid nozzle chamber 462 ). The top rod 438 a of the arm 438 can be connected to the slide 432 at the hinge 437 .

[0062] As the trigger 440 is depressed, the trigger 440 may compress the spring 450. The spring 450 may be operably coupled to a button valve 460. The button valve 460 may function to allow and disallow flow from the source 24 through the fluid inlet 420.

[0063] Figure 5A A first configuration of the metering mechanism 430 is shown. Figure 5A In the configuration of FIG. 4 , the spring 450 is in a relaxed, uncompressed state, which biases the trigger 440 to Figure 5A The opening 436 of the sliding member 432 may be offset from the medicine inlet 418 so that the medicine 16 does not pass through the opening 436 and the medicine inlet 418 .

[0064] In use, an operator may depress a trigger 440, which may be an example of an actuation mechanism 30. A greater force may be required to compress the spring 450 than to open the button valve 460 to allow fluid from the source 24 to pass through the fluid inlet 420. For example, the compression of the trigger 440 required to depress the button 461 of the button valve 460 and open the button valve 460 may be approximately 0.075 inches. Additionally or alternatively, the spring 450 may be partially compressed to open the button valve 460, and further compression of the spring 450 may be required to fully translate the opening 436 communicating with the medicament inlet 418. The further compression of the trigger 440 required to compress the spring 450 may be approximately 0.33 inches. Thus, the total displacement of the trigger 404 may be approximately 0.504 inches. The force of depressing the trigger 440 may cause the spring 45 to begin translating to open the button valve 460 and initiate fluid flow from the source 24 through the fluid inlet 420. The fluid may flow into the fluid inlet 420 and into the fluid nozzle chamber 462. The fluid may pass through the opening 462 of the fluid nozzle chamber 462 and into the mixing chamber 464. The fluid then exits through the outlet 34. In the first configuration, the medicament 16 is not delivered through the outlet 434 because the opening 436 is not aligned with the medicament inlet 418.

[0065] Thereafter, as the force acting on the trigger 440 increases, the spring 450 will be compressed (or further compressed). The compression of the spring 450 will enable the arm 438 to rotate about the axis C (or further about the axis C). The rotation of the arm 438 can correspondingly cause the slider 432 to translate in the first direction (translate to the left in the figure), thereby aligning the opening 436 with the medicament inlet 418, thereby causing the metering mechanism 430 to transition to Figure 5B In the second configuration, the fluid from source 24 may continue to flow as described above with respect to the first configuration ( Figure 5A). Because opening 436 is aligned with and in fluid communication with medicament inlet 418, medicament 16 also passes through opening 436 and medicament inlet 418. Medicament 16 may then enter mixing chamber 464, where the medicament may mix with the fluid from source 24. The mixed medicament 16 and fluid may then be delivered via outlet 434.

[0066] The trigger 440 may include an opening 470 , which may be, for example, oval in shape. The opening 470 may receive a component (not shown) coupling the trigger 440 to the spring 450 while allowing the necessary movement of the trigger 440 relative to the stationary spring 450 and the button valve 460 .

[0067] When the user releases the trigger 440, the spring 450 may first be depressurized, causing the slider 432 to return to a configuration that misaligns the opening 436 with the medicament inlet 418. Because the opening 436 is offset from the medicament inlet 418, the medicament 16 will not pass through the medicament inlet 418. However, because the button valve 460 will still remain in the open state, fluid can continue to flow from the source 24 through the fluid inlet 20 for a certain time until the button valve 460 is closed.

[0068] Body 412 can facilitate delivery of fluid from source 24 free of or substantially free of medicament 16 through outlet 434, both before and after delivery of medicament 16. Such delivery of fluid from source 24 free of or substantially free of medicament 16 can flush system 10, thereby reducing or eliminating clogging.

[0069] Figure 6A-6B Another exemplary body 512 that may be a component of system 10 is shown. Body 512 may have Figure 2A-2C Any feature of the body 112. As used herein, Fig. 6A and Figure 6B The description of 512 emphasizes the differences between the body 112 and the body 512. The fluid inlet 520 of the body 512 is in direct fluid communication with the fluid nozzle chamber 610 without the fluid first passing through the cavity 600. The valve 538 may include only one stem portion 550, which may have any of the characteristics of the second portion 150. The stem portion 550 may include an opening 552 (similar to the opening 152) and may be sealingly slidable within the cavity 600.

[0070] Flow to the fluid inlet 520 can be controlled using valve 522, which can be, for example, a push button valve. Valve 522 can be actuated independently of valve 538. Thus, valve 522 can be opened to allow flow of fluid into the fluid inlet 520 and out of the outlet 534. At the same time, valve 538 can be actuated separately to allow flow of medicament 16 through medicament inlet 518.

[0071] Fig. 6A A first configuration is shown in which valve 522 is closed and valve 538 is in a first configuration in which opening 552 is not aligned with (not in fluid communication with) medicament inlet 518. In the first configuration, fluid does not pass through fluid inlet 520, and medicament does not pass through medicament inlet 518, such that neither fluid nor medicament is delivered via outlet 534.

[0072] Figure 6B A second configuration is shown, wherein valve 522 is open and valve 538 is in a second configuration, wherein opening 552 is aligned with medicament inlet 518 for fluid communication with medicament inlet 518. In the second configuration, fluid may pass through fluid inlet 520 and medicament 16 may pass through medicament inlet 518, such that the fluid and medicament 16 mix in mixing chamber 514 and are delivered out of outlet 534.

[0073] The body 512 may be configured so that the valve 538 can be driven to the second configuration only when the valve 522 is open. Therefore, if the fluid from the source 24 is not also delivered to the mixing chamber 514, the medicament 16 will not enter the mixing chamber 514. In operation, the user can activate the first actuation mechanism 530 (which can be, for example, a button of the valve 522). The fluid can flow through the body 512 and flow out of the outlet 534. Then, the user can activate the second actuation mechanism (not shown) to transition the valve 538 to the second configuration to deliver a mixture of the medicament 16 and the fluid. The user cannot release the first actuation mechanism 530 without first releasing the second actuation mechanism. After the second actuation mechanism is released, the valve 538 can be transformed back to the first configuration of the valve 538 due to the restoring force of the spring 568, which can have any characteristics of the second spring 168. Then, the user can release the first actuation mechanism 530 to close the valve 522 and prevent the flow of fluid through the fluid inlet 520.

[0074] Body 512 can facilitate delivery of fluid from source 24 free of or substantially free of medicament 16 through outlet 534, both before and after delivery of medicament 16. Such delivery of fluid from source 24 free of or substantially free of medicament 16 can flush system 10, thereby reducing or eliminating blockages.

[0075] Figure 7A-7D Aspects of a body 712 that may form part of the delivery system 10 are shown. Figure 7A-7B shows a cross-sectional view of the body 712 in a first configuration and a second configuration, respectively, and Figure 7C-D Aspects of a turbine 750 are shown, which may be a component of the body 712 .

[0076] As in Fig. 7A and Figure 7BAs shown in FIG. 7 , the body 712 may have a medicament inlet 718 , a fluid inlet 720 , and an outlet 734 that are fluidly connected to each other via a chamber 752 .

[0077] The turbine 750 may be disposed in the chamber 752. The turbine 750 may include a plurality of blades 754 extending radially outward from a center body 756 (see FIG. Figure 7C-D ). Although three blades 754 are shown, it should be understood that other numbers of blades 754 may be used. The blades 754 may have any suitable shape, including the shapes shown. The blades 754 may be made of any suitable material, including rigid or flexible materials (such as metal or plastic). The turbine 750 may also have a blocking mechanism 758, which may extend radially outward from the center body 756. The blocking mechanism 758 may have any suitable shape (including a wedge shape), which may be a curved wedge shape. The blocking mechanism 758 may be made of any suitable material (including a rigid material).

[0078] The turbine 750 can be fixedly connected to the shaft 760 and can rotate about the shaft 760. The shaft 760 can extend from the central body 756 and can also be fixedly connected to a circular gear 762, which can include teeth. The turbine 750 and the gear 762 can rotate in unison via the shaft 760. The gear 762 can be constructed of any suitable material and can include any suitable number of teeth. The turbine 750 and the gear 762 can have any suitable size.

[0079] The gear 762 may interact with a linear rack 764. The linear rack 764 may move relative to the gear 762 in a direction transverse to the longitudinal axis of the medicament inlet 718 (e.g., perpendicular to the medicament inlet 718, left / right direction in the drawings). The rack 764 may include an opening 764a formed therein. A spring 770 may extend from an end of the rack 764 farthest from the gear 762, and a first end of the spring 770 may be fixed relative to the rack 764. A second end of the spring 770 may be fixed relative to a surface 772 defining the chamber 752.

[0080] exist Fig. 7A In the first configuration shown in FIG. 1 , the actuating mechanism 30 ( FIG. 1 ) may not be activated, and the fluid may not flow from the source 24 to the fluid inlet 720. The turbine 750, the gear 762, and the rack 764 may each be stationary. The spring 770 may be in a relaxed state. The rack 764 may be positioned so that the opening 764a is not aligned with the medicament inlet 718 (not in fluid communication with the medicament inlet 718). The rack 764 may include a seal 765 to prevent the medicament from moving between the outer surface of the rack 764 and the surface of the chamber 752. In the first configuration, the medicament 16 will not enter the chamber 752 because the opening 764a is not aligned with the medicament inlet 718 (not in fluid communication with the medicament interface 718).

[0081] When the actuation mechanism ( FIG. 1 ) is activated, flow from the source 24 to the fluid inlet 720 may be permitted. The fluid from the fluid inlet 720 may interact with the blades 754 to cause the turbine 750 to rotate. The rotation of the turbine 750 may cause a corresponding rotation of the gear 762. The rotation of the gear 762 may cause the rack 764 to translate in a first direction (toward the left in the figure), so that the opening 764a moves to a position closer to the medication inlet 718. As the rack 764 translates, the spring 770 may be compressed because the force of the fluid acting on the turbine 750 may overcome the restoring force of the spring 770. Figure 7B , in the second configuration of the body 712, the opening 764a can be aligned with (in fluid communication with) the medicament inlet 718. Thus, the medicament 16 can be allowed to flow through the opening 764a into the chamber 752. In the chamber 752, the medicament 16 can mix with the fluid from the source 24 and then exit through the outlet 734. However, before the opening 764a is aligned with (in fluid communication with) the medicament inlet 718, only the fluid from the source 24 can flow through the chamber 752 and exit the outlet 734.

[0082] Activation of the actuation mechanism 30 may immediately or after a delay cause the protrusion 780 to extend from the surface 772 of the body 712. The protrusion 780 may extend in a direction perpendicular to the axis 760. Figure 7C The turbine 750 and the protrusion 780 are shown before the protrusion 780 is extended (eg, before activation of the actuation mechanism 30 ). Fig.7D The turbine 750 and the protrusion 780 are shown after the protrusion 780 has extended from the surface 772. The protrusion 780 can interact with the stop mechanism 758 to prevent further rotation of the turbine 750 after the stop mechanism 758 contacts the protrusion 780. The protrusion 780 and the stop mechanism 758 can prevent the gear 762 from continuing to rotate and thereby prevent the rack 764 from translating beyond a desired position in which the opening 764a is aligned with the medicament inlet 718.

[0083] When the actuation mechanism 30 is released, the flow of fluid through the fluid inlet 720 can be eliminated or reduced, thereby eliminating or reducing the force acting on the blade 754. The restoring force of the spring 770 can overcome the force (if any) of the fluid acting on the turbine 750, thereby causing the rack 764 to translate in a second direction opposite to the first direction. The rack 764 can correspondingly cause the rotation of the gear 762, which can cause the turbine 750 to rotate in a direction opposite to the direction of rotation when translating from the first configuration to the second configuration. The protrusion 780 can also be retracted. The opening 764a is no longer aligned with the medicament inlet 718 (in fluid communication with the medicament inlet 718), so the medicament 16 can no longer flow through the medicament inlet 718. In the case where the flow of part of the fluid through the fluid inlet 720 continues, the fluid can continue to leave the outlet 734 after the flow of the medicament 16 has stopped. Alternatively, the body 712 may include a cleaning conduit that needs to be actuated by another mechanism (e.g., a button). Alternatively, the actuation mechanism 30 may have three positions. In the first position of the actuation mechanism 30, no fluid flow through the fluid inlet 720 occurs. In the second position, fluid flow may be allowed, but the protrusion 780 or another component may interact with the rack 764 to prevent the movement of the rack 764 before the opening 764a is aligned with the medicament inlet 718, thereby preventing the flow of the medicament 16. In the second position, the protrusion 780 or another component may be retracted / deactivated to allow the rotation of the turbine 750 and allow the flow of the medicament 16 while the fluid flows through the fluid inlet 720. Alternatively, the gear ratio between the gear 762 and the linear rack 764, the length of the rack 764, and the strength of the spring 770 may be selected so that when the actuation mechanism 30 is activated, there will be a known duration and / or a known amount of fluid flow from the fluid inlet 720 before the opening 764a is aligned with the medicament inlet 718, thereby providing a flow of fluid without the medicament 16. After the opening 764a is aligned with the medicament inlet 718, the medicament 16 may flow through the medicament inlet 718. If the user desires flow of fluid after delivery of the medicament 16, the user may release the actuation mechanism 30 and restart the actuation mechanism 30. The user may activate the actuation mechanism only for a certain amount of time, so that the fluid flows but the medicament does not flow (because the opening 764a is not aligned with the medicament inlet 718).

[0084] Body 712 may facilitate delivery of fluid from source 24 through outlet 734 prior to delivery of medicament 16 and after delivery of medicament 16. This delivery of fluid from source 24 may flush system 10, thereby reducing or eliminating clogging.

[0085] Although the principles of the present disclosure are described herein with reference to illustrative examples for specific purposes, it should be understood that the present disclosure is not limited thereto. Personnel with ordinary skills in the art and who can obtain the teachings provided herein will recognize that other modifications, uses, and replacements of equivalents all fall within the scope of the examples described herein. Therefore, the present invention is not considered to be limited by the foregoing description.

Claims

1. A device for delivering a drug, comprising: a body including a housing for storing a medicament, a chamber downstream of the housing, and an inlet and an outlet each in fluid communication with the chamber; and a valve positioned within the body downstream of the housing and upstream of the chamber, the valve including an opening extending through the valve; in, The valve is configured to be movable relative to the body between the following two configurations: a first configuration in which an opening of the valve is offset from each of the housing and the chamber such that the valve is configured to prevent the flow of medicament from the housing and into the chamber; and a second configuration in which an opening of the valve is aligned with each of the housing and the chamber such that the valve is configured to allow the medicament to flow out of the housing and into the chamber; Among them, the main configuration is: delivering the fluid received from the inlet to the chamber, mixing the fluid received from the inlet with the medicament received from the housing through the valve in the chamber, and The mixture of fluid and medicament is delivered out of the chamber through the outlet. 2 . The device of claim 1 , further comprising an actuator configured to move the valve between the first configuration and the second configuration.

3. The device of claim 1, wherein in a first configuration, the housing is not in fluid communication with the chamber, and in a second configuration, the housing is in fluid communication with the chamber via a valve.

4. The device according to claim 1, wherein: The valve is configured to move from the first configuration to the second configuration only when fluid flows from the inlet through the chamber.

5. The device of claim 1, wherein the valve comprises a first portion, a second portion separated from the first portion by the opening, and a spring configured to connect the first portion to the second portion.

6. The device according to claim 1, wherein: When the valve is in the first configuration, the body is configured to convey fluid received from the inlet through the chamber and out of the outlet, thereby preventing a medicament stored in the housing from entering the chamber and allowing fluid to flow through the outlet without the medicament.

7. The device of claim 1, further comprising a second valve configured to release fluid into the body through the inlet, wherein the valve and the second valve are configured to be independently actuated.

8. The device of claim 7, wherein the valve is selectively controlled by a first actuator and the second valve is selectively controlled by a second actuator, the first actuator being configured to actuate the valve only when the second valve is actuated by the second actuator.

9. The device of claim 1, wherein the housing and the chamber each include an inlet, and when the valve is in the first configuration, the opening of the valve is offset from the inlet of the housing and the chamber respectively.

10. The device of claim 9, wherein when the valve is in the second configuration, the respective inlets of the housing and the chamber are aligned with the opening of the valve.

11. A device for delivering a drug, comprising Drug source a body having a drug inlet for receiving a drug from a drug source and a fluid inlet for receiving a fluid from a fluid source; a mixing chamber for receiving the fluid and the agent; an outlet in fluid communication with the mixing chamber for delivering fluid and medicine; a valve, located between the outlet and the agent source, for controlling the flow of the fluid through the fluid inlet and the flow of the agent through the agent inlet; as well as An actuator operatively connected to the valve, the actuator being configured to: moving the valve to a first configuration to deliver a first flow of fluid substantially free of the medicament through the outlet; After delivering the first flow, moving the valve to a second configuration to deliver a second flow of the fluid and the medicament through the outlet; as well as After delivering the second flow, the valve is moved to a third configuration to deliver a third flow of fluid substantially free of medicament through the outlet.

12. The device of claim 11, wherein the valve is movable relative to the drug source to selectively block the drug inlet, and Wherein the valve is configured to control the release of the drug and the fluid when moved relative to the drug source and the fluid inlet.

13. The device according to claim 11, wherein: When in the first configuration, the valve is positioned relative to the medication source to block the medication inlet, wherein the valve is positioned relative to the drug source so as not to block the drug inlet when in the second configuration, and Wherein, the valve is positioned relative to the drug source to block the drug inlet when in the third configuration.

14. The device of claim 11, wherein the first configuration and the third configuration are identical; Wherein the actuator is configured to move the valve to a fourth configuration prior to delivering the first flow of fluid substantially free of medicament in which neither medicament is permitted to flow through the medicament inlet nor fluid is permitted to flow through the fluid inlet.

15. The device of claim 11, wherein the valve defines an opening, wherein in a first configuration the opening is not in fluid communication with the source of medication, and wherein in a second configuration the opening is in fluid communication with the source of medication.

16. A device for delivering a drug, comprising A main body, including a shell for storing a drug, a chamber located downstream of the shell, and an inlet and an outlet in fluid communication with the chamber; a valve positioned within the body between the inlet and the chamber, wherein the valve is configured to control the flow of a fluid from a fluid source through the inlet to the chamber; a door positioned within the body between the housing and the chamber, wherein the door is configured to control the flow of the medicament from the housing into the chamber, wherein the door is operably connected to the valve; an actuator operably connected to the valve, the actuator being configured to: moving the valve and the door to a first position to deliver a first flow of fluid substantially free of the agent into the chamber and out of the device through the outlet; After delivering the first stream, moving the valve and the door to a second position to mix the fluid and the medicament in the chamber into a second stream for delivery out of the device through the outlet; as well as After delivering the second flow, the valve and gate are moved to a third position to deliver a third flow of fluid substantially free of the medicament into the chamber and out of the device through the outlet.

17. A device according to claim 16, wherein the valve includes at least one narrowed portion, wherein the at least one narrowed portion is configured to control the flow of fluid from the fluid source to the chamber in response to movement of the valve within the channel of the body to align the at least one narrowed portion with the inlet.

18. The apparatus of claim 16, wherein the valve is movable in a first direction and a second direction perpendicular to a longitudinal axis of the inlet to move the door between the first position and the second position.

19. The apparatus of claim 16, wherein the actuator comprises a wire operably connected between the valve and the door, wherein the wire is configured to move the door from the first position to the second position in response to movement of the valve.

20. The device according to claim 19, wherein The body includes a stopper configured to abut against a surface of the door when the door is in the second position to stop further movement of the door relative to the body.

21. The device according to claim 16, wherein: The door is configured to be in a biased position against the housing when the valve is in the first position.

22. A device for delivering a drug, comprising a body having a drug inlet for receiving a drug from a drug source and a fluid inlet for receiving a fluid from a fluid source; a mixing chamber for receiving a fluid and a medicament, wherein the mixing chamber comprises a first opening aligned with the medicament inlet and a second opening aligned with the fluid inlet; an outlet in fluid communication with the mixing chamber for delivering the fluid and the medicament out of the device; a valve disposed between the mixing chamber and the source of medicament, wherein the valve is configured to control flow of medicament from the source of medicament to the mixing chamber and out of the device through the outlet; and An actuator operatively connected to the valve, the actuator being configured to: moving the valve to a first configuration to deliver a first flow of fluid substantially free of the agent into the mixing chamber through the second opening by closing the first opening; moving the valve to a second configuration to deliver a second flow of fluid into the mixing chamber through the second opening by opening the first opening and delivering the medicament into the mixing chamber through the first opening; as well as The valve is moved to a third configuration to deliver a third flow of fluid substantially free of medicament through the second opening into the mixing chamber by closing the first opening.

23. The device of claim 22, wherein the valve is pivotally coupled to a hinge arm, the hinge arm being operably connected to the actuator such that the actuator is configured to translate the slidable member along the longitudinal axis in response to pivoting the hinge arm.

24. The device according to claim 22 further includes a button valve coupled to the actuator, wherein the button valve is operable at a first compression value to move the valve to a first configuration, and the button valve is operable at a second compression value to move the valve to a second configuration, wherein the second compression value is greater than the first compression value.

25. The device of claim 22, wherein the valve includes a slidable member configured to slidably translate through the passage in the body, the slidable member including an opening formed therethrough.

26. The device of claim 25, wherein when the slidable member translates relative to the channel toward the second configuration, the opening moves into alignment with the medicament source and the inlet of the mixing chamber such that the slidable member is configured to receive the medicament within the slidable member through the opening.

27. A device for delivering a drug, comprising A body, comprising a housing for storing a drug, a chamber downstream of the housing, and an inlet and an outlet in fluid communication with the chamber; a valve located within the body between the housing and the chamber, the valve being configured to control the flow of the medicament from the housing to the outlet via the chamber located upstream of the outlet; an actuator operatively connected to the valve, the actuator being configured to: moving the valve to a first position to deliver a first flow of fluid substantially free of the agent through the chamber toward the outlet; After delivering the first flow of fluid, moving the valve to a second position to deliver a second flow of fluid to the chamber for mixing with the medicament and then to the outlet; as well as After the second flow of fluid is delivered, the valve is moved to a third position to deliver a third flow of fluid substantially free of the agent through the chamber to the outlet.

28. The apparatus of claim 27, wherein when the actuator is activated, the first flow of fluid is configured to move the valve from the first position to the second position, and the second flow of fluid is configured to move the valve from the second position to the third position.

29. The apparatus of claim 27, further comprising a turbine disposed within the chamber, the turbine comprising a center body and a plurality of blades extending radially outward from the center body.

30. The apparatus of claim 29, wherein the turbine is configured to rotate in response to the chamber receiving a second flow of fluid through the chamber, thereby driving the plurality of blades to rotate the center body about the axis.

31. The apparatus of claim 29, wherein the turbine is movably coupled to the valve, the turbine being configured to rotate within the chamber to translate the valve relative to the housing.

32. The device of claim 27, wherein the valve includes an opening that is selectively aligned and misaligned with the medicament inlet of the housing to establish fluid communication between the housing and the chamber.

33. The apparatus of claim 29, further comprising a protrusion configured to interact with a blocking mechanism of the turbine to prevent rotation of the turbine beyond a rotational orientation corresponding to the second position of the valve when contacting the blocking mechanism.

34. A device for delivering a medicament, comprising: a body including a housing for storing a medicament, a chamber located downstream of the housing, a medicament inlet, a fluid inlet, and an outlet in fluid communication with the chamber; a nozzle positioned within the body between the housing and the chamber, wherein the nozzle is configured to control fluid flow from the fluid inlet; an actuator operably connected to the nozzle, the actuator being configured to: releasing a first flow of fluid substantially free of the agent through an outlet; delivering a second flow of the fluid together with the medicament through the outlet after delivering the first flow of the fluid; and After delivering the second flow, a third flow of fluid substantially free of the medicament is delivered through the outlet.